THQ logo

Tekla Healthcare Opportunities Fund (THQ) EBITDA

Quarterly EBITDA

N/A

30 September 2024

THQ Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

N/A

30 September 2024

THQ TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

THQ EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

THQ EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Tekla Healthcare Opportunities Fund EBITDA History

DateAnnualQuarterlyTTM
Mar 2020
-
-$52.88 M(+511.5%)
-$61.53 M(+611.5%)
Sept 2019
-
-$8.65 M(<-9900.0%)
-$8.65 M(-103.0%)
DateAnnualQuarterlyTTM
Mar 2019
-
$0.00(-100.0%)
$291.80 M(0.0%)
Sept 2018
-
$291.80 M
$291.80 M

FAQ

  • What is the all time high quarterly EBITDA for Tekla Healthcare Opportunities Fund?
  • What is the all time high TTM EBITDA for Tekla Healthcare Opportunities Fund?

What is the all time high quarterly EBITDA for Tekla Healthcare Opportunities Fund?

Tekla Healthcare Opportunities Fund all-time high quarterly earnings before interest, taxes, depreciation & amortization is $291.80 M

What is the all time high TTM EBITDA for Tekla Healthcare Opportunities Fund?

Tekla Healthcare Opportunities Fund all-time high TTM earnings before interest, taxes, depreciation & amortization is $291.80 M